Latent Tuberculosis Infection Detection Market Exclusive Report on the Latest Revenue and Future Scope

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Latent Tuberculosis Infection Detection Market - (By Brand (QFT-Plus), By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Release Assay (IGRA)), By Application, By End-use), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Latent Tuberculosis Infection Detection Market is valued at US$ 1.53 Bn in 2023, and it is expected to reach US$ 2.37 Bn by 2031, with a CAGR of 5.7% during the forecast period of 2024-2031.

Request for free Sample Pages:
https://www.insightaceanalytic.com/request-sample/2579

Latent Tuberculosis Infection (LTBI) refers to a condition in which individuals are infected with Mycobacterium tuberculosis yet do not exhibit active disease symptoms. Early detection of LTBI is critical to preventing its progression to active tuberculosis (TB). Market growth is driven by an increased risk of developing active TB and heightened public awareness regarding early diagnosis. Contributing factors include a significant rise in the geriatric population and a growing incidence of tuberculosis among older individuals.

Government initiatives aimed at raising awareness about TB prevention, along with the development of novel diagnostic solutions, are expected to significantly bolster market expansion during the forecast period. This market involves the production and distribution of diagnostic tools and tests-such as interferon-gamma release assays (IGRAs) and tuberculin skin tests (TSTs)-that are essential for LTBI detection. As global efforts to control TB transmission intensify, the demand for accurate and reliable LTBI diagnostic methods is anticipated to further drive market growth.

List Of Prominent Players In The Latent Tuberculosis Infection Detection Market:
• QIAGEN
• BIOMÉRIEUX
• Oxford Immunotec
• SD Biosensor, INC.
• Wantai BioPharm
• Lionex GmbH
• Sanofi
• Serum Institute of India Pvt. Ltd
• ARKRAY, Inc.
• Par Pharmaceutical, Inc.
• Abbott,
• F. Hoffmann-La Roche Ltd
• Other Prominent Players

Market Dynamics:
Drivers-
A key driver of the global latent tuberculosis infection (LTBI) testing market is the growing elderly population. Older individuals are particularly susceptible to latent TB due to age-related declines in immune function and a higher likelihood of adverse drug reactions, complicating tuberculosis management in this demographic. Additionally, rapid urbanization, the increasing prevalence of HIV, enhanced TB funding, accelerated construction activities, rising consumer expenditure, and proactive government initiatives have collectively contributed to market growth.

Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2579

Challenges:
The LTBI detection market faces significant challenges, including the emergence of multidrug-resistant tuberculosis (MDR-TB) and the impact of stringent government regulations. MDR-TB complicates treatment protocols and amplifies the need for precise and timely diagnostic methods. Moreover, strict regulatory frameworks can impede the market entry of innovative diagnostic technologies and slow the adoption of new solutions. Overcoming these challenges will require advanced research into more effective detection techniques, enhanced collaboration with regulatory bodies to streamline approval processes, and educational programs to raise awareness of the importance of early detection and treatment of latent tuberculosis infections.

Regional Trends:
In North America, the LTBI detection market is expected to experience substantial growth due to increasing awareness and robust TB control initiatives. Factors contributing to this growth include significant advancements in diagnostic techniques, a rising prevalence of TB, and strong support from governmental health agencies. The presence of major industry players investing in research and development to improve detection accuracy further bolsters market expansion. Additionally, comprehensive screening programs targeting high-risk populations are driving demand. Europe also maintains a notable market share, bolstered by the influence of leading research institutes and key market stakeholders.

Recent Developments:
• In March 2024, QIAGEN formed a cooperation with the International Panel Physicians Association (IPPA) to provide education and assistance to panel physicians throughout the world regarding the most up-to-date tuberculosis screening needs. The primary emphasis will be on the novel IGRA prerequisites and their advantageous implications for patients and healthcare professionals.

Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/2579

Segmentation of latent tuberculosis infection detection market-
By Brand -
• QFT-Plus (QuantiFERON-TB Gold Plus)
• Others
By Test Type -
• Tuberculin Skin Test (TST)
• Interferon Gamma Release Assay (IGRA)
By Application -
• Household Contacts with Pulmonary TB
• PLHIV
• Others
By End-Use -
• Diagnostic Laboratories
• Hospitals/Clinics
• Academic & Research Institutions
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Get more information: @
https://www.insightaceanalytic.com/report/latent-tuberculosis-infection-detection-market/2579

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG

Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

This release was published on openPR.